In today’s briefing:
- Companies Should Communicate Their Human Resources Strategy Rather than Detailed Disclosure Rules
- Regeneron Pharmaceuticals: The Libtayo Stake Acquisition & Other Driver
Companies Should Communicate Their Human Resources Strategy Rather than Detailed Disclosure Rules
- Companies had expected detailed rules, as with various disclosure documents, but was puzzled by government’s guidelines, which were conceptual and didn’t provide guidance on what to disclose and how much.
- It is likely that the disclosure in annual securities reports, which are legal documents, will fill the space by disclosing items that are specifically identified and easy to show quantitatively.
- Companies that cannot clearly explain their policies on investment in human capital and human resource strategies in their management strategies are unlikely to attract human resources.
Regeneron Pharmaceuticals: The Libtayo Stake Acquisition & Other Driver
- Regeneron had a successful second quarter surpassing Wall Street expectations on all counts with noteworthy performance in every segment.
- The company made considerable pipeline progress in addition to having good commercial execution, with 3 regulatory approvals, 2 accepted regulatory filings, and 1 positive Phase III readout.
- After five years and more than 450,000 patients treated since its launch, Dupixent is still expanding at a good rate.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
